Mydecine Innovations Group Management
Management criteria checks 3/4
Mydecine Innovations Group's CEO is Josh Bartch, appointed in Jul 2018, has a tenure of 6.33 years. directly owns 0.61% of the company’s shares, worth £1.60K. The average tenure of the management team and the board of directors is 4 years and 4.4 years respectively.
Key information
Josh Bartch
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.3yrs |
| CEO ownership | 0.6% |
| Management average tenure | 4yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -CA$12m |
| Jun 30 2024 | n/a | n/a | -CA$12m |
| Mar 31 2024 | n/a | n/a | -CA$11m |
| Dec 31 2023 | n/a | n/a | -CA$21m |
| Sep 30 2023 | n/a | n/a | -CA$19m |
| Jun 30 2023 | n/a | n/a | -CA$20m |
| Mar 31 2023 | n/a | n/a | -CA$21m |
| Dec 31 2022 | CA$445k | CA$383k | -CA$16m |
| Sep 30 2022 | n/a | n/a | -CA$23m |
| Jun 30 2022 | n/a | n/a | -CA$18m |
| Mar 31 2022 | n/a | n/a | -CA$24m |
| Dec 31 2021 | CA$2m | CA$346k | -CA$24m |
| Sep 30 2021 | n/a | n/a | -CA$19m |
| Jun 30 2021 | n/a | n/a | -CA$37m |
| Mar 31 2021 | n/a | n/a | -CA$32m |
| Dec 31 2020 | CA$819k | CA$153k | -CA$27m |
| Sep 30 2020 | n/a | n/a | -CA$39m |
| Jun 30 2020 | n/a | n/a | -CA$23m |
| Mar 31 2020 | n/a | n/a | -CA$20m |
| Dec 31 2019 | CA$238k | CA$238k | -CA$21m |
| Sep 30 2019 | n/a | n/a | -CA$5m |
| Jun 30 2019 | n/a | n/a | -CA$5m |
| Mar 31 2019 | n/a | n/a | -CA$11m |
| Dec 31 2018 | CA$425k | CA$302k | -CA$13m |
Compensation vs Market: Insufficient data to establish whether Josh's total compensation is reasonable compared to companies of similar size in the UK market.
Compensation vs Earnings: Josh's compensation has been consistent with company performance over the past year.
CEO
Josh Bartch (36 yo)
6.3yrs
Tenure
CA$444,518
Compensation
Mr. David Joshua Bartch, also known as Josh, serves as Chairman of the Board at Mydecine Innovations Group Inc. Mr. Bartch is Co-Founder of Mydecine Innovations Group Inc. and serves as its President, Chie...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 6.3yrs | CA$444.52k | 0.61% £ 1.6k | |
| Co-Founder | 4.5yrs | CA$455.31k | 0.21% £ 541.6 | |
| Co-Founder & COO | 4.5yrs | CA$455.31k | 0.15% £ 386.5 | |
| CFO & Corporate Secretary | 2.2yrs | CA$9.20k | no data | |
| Chief Compliance Officer & General Counsel | 4.1yrs | CA$317.36k | no data | |
| Chief Medical Officer | 4yrs | CA$271.20k | no data | |
| Director of Marketing | no data | no data | no data | |
| President of the European Operations | 3.7yrs | no data | no data | |
| Interim CEO & Technical Director of Mindleap Health Inc. | 3.5yrs | no data | no data |
4.0yrs
Average Tenure
Experienced Management: MYIG's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 6.4yrs | CA$444.52k | 0.61% £ 1.6k | |
| Co-Founder | 3.9yrs | CA$455.31k | 0.21% £ 541.6 | |
| Member of Medical | 4.4yrs | no data | no data | |
| Member of Medical | 4.4yrs | no data | no data | |
| Member of Medical | 4.4yrs | no data | no data | |
| Member of Medical | no data | no data | no data | |
| Member of Medical | no data | no data | no data | |
| Member of Medical | no data | no data | no data | |
| Member of Medical | no data | no data | no data | |
| Member of Medical | no data | no data | no data | |
| Member of Medical | 4.3yrs | no data | no data | |
| Member of Medical | 4.3yrs | no data | no data |
4.4yrs
Average Tenure
Experienced Board: MYIG's board of directors are considered experienced (4.4 years average tenure).